HYPD
Hyperion DeFi, Inc.
There isn't enough reported data to score HYPD yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
HYPD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Unavailable | |
| Unavailable |
HYPD's revenue is currently strong, and its profitability is stable. There isn't enough data to rate its cash flow and balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
HYPD PE Valuation
HYPD has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
HYPD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect HYPD's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
HYPD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.78 | — |
| Q2 2025 | -$35.84 | +$27.36 |
| Q1 2025 | -$50.14 | +$9.06 |
| Q4 2024 | -$66.95 | -$14.15 |
| Q3 2024 | -$57.60 | -$5.60 |
| Q2 2024 | -$63.20 | -$8.80 |
| Q1 2024 | -$59.20 | $0.00 |
| Q4 2023 | -$52.80 | +$13.60 |
| Q3 2023 | -$52.00 | -$8.00 |
LLY has the stronger earnings trend. Trailing diluted EPS is down 157% for HYPD versus LLY up 51%.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.83 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY's earnings per share have climbed steadily: $30.81 over the past year, up 51% from the year before, and higher year over year for 11 quarters in a row.
HYPD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $244.3K | +1559% |
| Q4 2025 | $496.2K | +1666% |
| Q3 2025 | $302.5K | +18516% |
| Q1 2025 | $14.7K | +195% |
| Q4 2024 | $28.1K | +985% |
| Q3 2024 | $1.6K | +36% |
HYPD's revenue has grown year over year for four quarters in a row: $357,693 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8669% | N/A |
| Q1 2026 | 3575% | +24164 points |
| Q4 2025 | -8013% | +61225 points |
| Q3 2025 | 1464% | +452659 points |
| Q1 2025 | -20589% | +185035 points |
| Q4 2024 | -69238% | +219157 points |
| Q3 2024 | -451196% | +93060 points |
| Q2 2024 | -51661% | N/A |
HYPD has the edge over LLY on profitability, with a higher operating margin.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over HYPD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
HYPD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$6.1M | +$356.5K |
| Q3 2024 | -$5.9M | +$475.6K |
| Q2 2024 | -$8.2M | -$2.3M |
| Q1 2024 | -$10M | -$2.1M |
| Q4 2023 | -$6.5M | -$1M |
| Q3 2023 | -$6.4M | +$624K |
| Q2 2023 | -$5.9M | -$1.1M |
| Q1 2023 | -$7.9M | +$479.4K |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with HYPD at down 12%.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY generated $19.7B in free cash flow over the past year, up 112% from the year before.
HYPD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +61% | +1.3M shares |
| 1 year | +430% | +2.9M shares |
| 3 years | +737% | +3.1M shares |
| 5 years | +1320% | +3.3M shares |
HYPD has 4M diluted shares, up 430% from a year ago.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over HYPD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
HYPD Net Leverage
HYPD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
HYPD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.4 | Neutral |
| Stochastic | 25.1 | Neutral |
HYPD's weekly RSI is 43 (neutral) and its Stochastic is 25 (neutral).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
HYPD PE vs Healthcare Sector
HYPD has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
HYPD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.16 | 14% below |
| 20 week MA | $3.09 | 12% below |
| 50 week MA | $3.34 | 19% below |
| 100 week MA | $4.42 | 38% below |
| 200 week MA | $68.7 | 96% below |
HYPD is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over HYPD on trend strength, trading above more of its moving averages.
HYPD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $305.6 | $455.2 | +49% |
| 2021 | $455.2 | $329.6 | -28% |
| 2022 | $329.6 | $128.8 | -61% |
| 2023 | $128.8 | $166.4 | +29% |
| 2024 | $166.4 | $7.52 | -95% |
| 2025 | $7.52 | $3.84 | -49% |
| 2026 YTD | $3.84 | $2.72 | -29% |
HYPD has finished lower in four of the last six years. It's down 29% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over HYPD on returns for 2026, with the stronger performance.